Effects of PH3 in Diabetic Nephropathy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01068041

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
PhytoHealth Corporation (from the registry)
Registry
  • NCT NCT01068041
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01068041. Randomized; quadruple masking; primary purpose prevention. Start 2010-08 (registry gives no type); primary completion 2014-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of PH3 in Diabetic Nephropathy
Acronym
PH3
Condition
Diabetic Nephropathy
Intervention (Drug)
PH3
Lead sponsor
PhytoHealth Corporation (class: industry)

Record details

Record id
cardio:ct-nct01068041
Content hash
555433446c7eb9c425d88aef571af13fff8492c82dabc91f3f814ef138e90a7a